-+ 0.00%
-+ 0.00%
-+ 0.00%

Q/C TECHNOLOGIES - SERIES G AND SERIES H AMENDMENTS MODIFY BENEFICIAL OWNERSHIP LIMITATIONS FOR PHARMACYTE - SEC FILING

Reuters·11/20/2026 22:27:02